The ENIGMA Study: Eastern Inflammatory Bowel Disease Gut Microbiota
Sponsor: Chinese University of Hong Kong
Listed as NCT03462875, this observational or N/A phase trial focuses on Crohn Disease and remains ongoing. Sponsored by Chinese University of Hong Kong, it has been updated 11 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Mar 2025 — Present [monthly]
Unknown
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Mar 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Mar 2023 — Jul 2024 [monthly]
Active Not Recruiting
-
Sep 2021 — Mar 2023 [monthly]
Active Not Recruiting
Status: Unknown Status → Active Not Recruiting
▶ Show 6 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting
-
Aug 2018 — Nov 2020 [monthly]
Not Yet Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Not Yet Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Chinese University of Hong Kong
- Kunming Medical University
- Sun Yat-sen University
- The University of Queensland
- University of Melbourne
For direct contact, visit the study record on ClinicalTrials.gov .